Xuejiao Liu
7PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 05, 2024
Retraction Note: GRP78 determines glioblastoma sensitivity to UBA1 inhibition-induced UPR signaling and cell death.Guanzheng Liu, Jiefeng Yu, Runqiu Wu
|Aug 07, 2023
Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment.Tongxuan Guo, Changyong Wu, Lingni Zhou
|Mar 29, 2022
GRP78 blockade overcomes intrinsic resistance to UBA1 inhibitor TAK-243 in glioblastoma.Xu Zhang, Runqiu Wu, Cong Tian
|Jul 24, 2021
GRP78 determines glioblastoma sensitivity to UBA1 inhibition-induced UPR signaling and cell death.Guanzheng Liu, Jiefeng Yu, Runqiu Wu
|Jul 03, 2021
Csnk1a1 inhibition modulates the inflammatory secretome and enhances response to radiotherapy in glioma.Guanzheng Liu, Huan Li, Wanhong Zhang
|May 27, 2020
MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation.Xuejiao Liu, Chenglong Yue, Lin Shi
Pageof 2
